SLC9A1 and neoplasm: Therefore, NHE1 protein in GAMs plays a critical role in developing immunosuppressive GBM TME and its blockade emerges as a strategy for reinvigorating T-cells anti-tumor function in combination with TMZ and anti-PD-1 therapy.